Further, ablation of TLR4 on epithelial cells or inhibition through antagonists reduced recruitment and activation of sub-epithelial DCs and suppressed features of asthma such as bronchial hyperreactivity (87, 88). The gene discussed is TLR4; the disease is asthma.